131 results on '"Dabbs, David J."'
Search Results
2. Prosigna® breast cancer assay: histopathologic correlation, development, and assessment of size, nodal status, Ki-67 (SiNK™) index for breast cancer prognosis
3. The healthcare value of the Magee Decision Algorithm™: use of Magee Equations™ and mitosis score to safely forgo molecular testing in breast cancer
4. Metaplastic breast carcinoma: a clinical-pathologic study of 97 cases with subset analysis of response to neoadjuvant chemotherapy
5. Breast cancer global tumor biomarkers: a quality assurance study of intratumoral heterogeneity
6. Magee Equation 3 predicts pathologic response to neoadjuvant systemic chemotherapy in estrogen receptor positive, HER2 negative/equivocal breast tumors
7. 35 - Metastatic Tumors in the Breast
8. 32 - Neoplasia of the Male Breast
9. 30 - Rare Breast Carcinomas: Adenoid Cystic Carcinoma, Neuroendocrine Carcinoma, Secretory Carcinoma, Carcinoma With Osteoclast-like Giant Cells, Lipid-Rich Carcinoma, and Glycogen-Rich Clear Cell Carcinoma
10. 28 - Pathology of Neoadjuvant Therapeutic Response of Breast Carcinoma
11. 24 - Triple-Negative and Basal-like Carcinoma
12. 25 - Metaplastic Breast Carcinoma
13. 22 - Ductal Carcinoma In Situ
14. 21 - Lobular Neoplasia and Invasive Lobular Carcinoma
15. 23 - Invasive Ductal Carcinoma of No Special Type and Histological Grade
16. 19 - Columnar Cell Change, Flat Epithelial Atypia, and Atypical Ductal Epithelial Hyperplasia
17. 18 - Fibrocystic Change and Usual Epithelial Hyperplasia of Ductal Type Fibrocystic Change
18. 17 - Myoepithelial Lesions of the Breast
19. 16 - Radial Scar
20. 14 - Adenosis and Microglandular Adenosis
21. 9 - Predictive and Prognostic Marker Testing in Breast Pathology: Immunophenotypic Subclasses of Disease
22. 11 - Diagnostic Immunohistology of the Breast
23. 10 - Molecular-Based Testing in Breast Disease for Therapeutic Decisions
24. 6 - Gross Examination of Breast Specimens
25. 5 - Patient Safety in Breast Pathology
26. 3 - Infections of the Breast
27. 2 - Reactive and Inflammatory Conditions of the Breast
28. Erratum to Metaplastic Breast Carcinoma: A Clinical-Pathologic Study of 97 Cases With Subset Analysis of Response to Neoadjuvant Chemotherapy [Modern Pathology 32(6) (2019) 807–816]
29. Metastatic Tumors of Unknown Origin: Ancillary Testing in Cytologic Specimens
30. Invasive lobular carcinoma of the breast: Patient response to systemic endocrine therapy and hormone response in model systems
31. Prediction of the Oncotype DX recurrence score: use of pathology-generated equations derived by linear regression analysis
32. A validation study of quantum dot multispectral imaging to evaluate hormone receptor status in ductal carcinoma in situ of the breast
33. The effect of cold ischemic time on the immunohistochemical evaluation of estrogen receptor, progesterone receptor, and HER2 expression in invasive breast carcinoma
34. Semi-quantitative immunohistochemical assay versus oncotype DX® qRT-PCR assay for estrogen and progesterone receptors: an independent quality assurance study
35. 21 - Immunocytology
36. 19 - Immunohistology of the Breast
37. 8 - Immunohistology of Carcinoma of Unknown Primary Site
38. 1 - Techniques of Immunohistochemistry: Principles, Pitfalls, and Standardization
39. Semiquantitative hormone receptor level influences response to trastuzumab-containing neoadjuvant chemotherapy in HER2-positive breast cancer
40. Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists
41. Androgen receptor in breast cancer: expression in estrogen receptor-positive tumors and in estrogen receptor-negative tumors with apocrine differentiation
42. Contributors
43. Histopathologic variables predict Oncotype DX™ Recurrence Score
44. Clinical importance of HER2 immunohistologic heterogeneous expression in core-needle biopsies vs resection specimens for equivocal (immunohistochemical score 2+) cases
45. The ductal phenotypic expression of the E-cadherin/catenin complex in tubulolobular carcinoma of the breast: an immunohistochemical and clinicopathologic study
46. Molecular alterations in columnar cell lesions of the breast
47. Basal phenotype of ductal carcinoma in situ: recognition and immunohistologic profile
48. Improving Papanicolaou test quality and reducing medical errors by using Toyota production system methods
49. Lack of Standardization in the Diagnosis of Invasive Lobular Carcinoma of the Breast
50. Chapter 19 - Immunohistology of the Breast
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.